United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Gamma Biosciences to sell Mirus Bio to Merck KGaA for $600m in key biotech deal Merck KGaA, Darmstadt, Germany (XTRA:MRK), a leading global science and technology company, has agreed to acquire Mirus Bio… byPallavi MadhirajuMay 26, 2024